Frazier Life Sciences Management, L.P. Q3 2022 Filing
Filed November 14, 2022
Portfolio Value
$1.3T
Holdings
43
Report Date
Q3 2022
Filing Type
13F-HR
All Holdings (43 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | HLVXHILLEVAX INC | 9,758,359 | $166.8B | 12.84% | |
| 2 | ARQTARCUTIS BIOTHERAPEUTICS INC | 8,684,232 | $166.0B | 12.78% | |
| 3 | PHATPHATHOM PHARMACEUTICALS INC | 8,407,152 | $93.2B | 7.17% | |
| 4 | 290ACHINOOK THERAPEUTICS INC | 4,265,559 | $83.9B | 6.46% | |
| 5 | SNDXSYNDAX PHARMACEUTICALS INC | 3,412,838 | $82.0B | 6.31% | |
| 6 | MIRMMIRUM PHARMACEUTICALS INC | 3,827,781 | $80.4B | 6.19% | |
| 7 | KRYSKRYSTAL BIOTECH INC | 1,018,388 | $71.0B | 5.47% | |
| 8 | RYTMRHYTHM PHARMACEUTICALS INC | 1,894,000 | $46.4B | 3.57% | |
| 9 | —IMAGO BIOSCIENCES INC | 2,971,274 | $44.7B | 3.44% | |
| 10 | PCVXVAXCYTE INC | 1,547,405 | $37.1B | 2.86% | |
| 11 | COGTCOGENT BIOSCIENCES INC | 2,074,154 | $30.9B | 2.38% | |
| 12 | TARSTARSUS PHARMACEUTICALS INC | 1,787,527 | $30.6B | 2.36% | |
| 13 | ALLKGUSDALLAKOS INC | 4,792,000 | $29.3B | 2.26% | |
| 14 | CRNXCRINETICS PHARMACEUTICALS IN | 1,414,823 | $27.8B | 2.14% | |
| 15 | 1T7TRICIDA INC | 2,549,671 | $26.7B | 2.06% | |
| 16 | ANABANAPTYSBIO INC | 899,700 | $23.0B | 1.77% | |
| 17 | KALVKALVISTA PHARMACEUTICALS INC | 1,572,192 | $22.8B | 1.76% | |
| 18 | NVLSEURALPINE IMMUNE SCIENCES INC | 2,985,757 | $21.5B | 1.66% | |
| 19 | VRNAVERONA PHARMA PLC | 2,099,541 | $21.5B | 1.65% | |
| 20 | —FRAZIER LIFESCIENCES ACQU CO | 1,501,000 | $15.2B | 1.17% | |
| 21 | MRUSMERUS N V | 746,479 | $15.0B | 1.15% | |
| 22 | ACADACADIA PHARMACEUTICALS INC | 857,338 | $14.0B | 1.08% | |
| 23 | REPLREPLIMUNE GROUP INC | 806,267 | $13.9B | 1.07% | |
| 24 | 2JQGRITSTONE BIO INC | 5,237,348 | $13.5B | 1.04% | |
| 25 | ARVNARVINAS INC | 285,331 | $12.7B | 0.98% | |
| 26 | TYRATYRA BIOSCIENCES INC | 1,327,665 | $11.7B | 0.90% | |
| 27 | NTLAINTELLIA THERAPEUTICS INC | 203,684 | $11.4B | 0.88% | |
| 28 | CERE1EURCEREVEL THERAPEUTICS HLDNG I | 393,000 | $11.1B | 0.86% | |
| 29 | STROSUTRO BIOPHARMA INC | 1,776,479 | $9.9B | 0.76% | |
| 30 | GRCLGRACELL BIOTECHNOLOGIES INC | 2,890,102 | $9.3B | 0.72% | |
| 31 | —BLUEBIRD BIO INC | 1,440,757 | $9.1B | 0.70% | |
| 32 | SLNSILENCE THERAPEUTICS PLC | 881,173 | $8.7B | 0.67% | |
| 33 | TRVITREVI THERAPEUTICS INC | 5,403,590 | $8.3B | 0.64% | |
| 34 | AUTLAUTOLUS THERAPEUTICS PLC | 3,746,857 | $8.0B | 0.62% | |
| 35 | ACRSACLARIS THERAPEUTICS INC | 408,329 | $6.4B | 0.49% | |
| 36 | PASGPASSAGE BIO INC | 3,756,915 | $4.7B | 0.36% | |
| 37 | IMVTIMMUNOVANT INC | 585,759 | $3.3B | 0.25% | |
| 38 | MGNXMACROGENICS INC | 701,631 | $2.4B | 0.19% | |
| 39 | —PARDES BIOSCIENCES INC | 845,636 | $1.6B | 0.12% | |
| 40 | EPIEURESSA PHARMA INC | 692,910 | $1.3B | 0.10% | |
| 41 | —MOLECULAR TEMPLATES INC | 1,374,047 | $1.0B | 0.08% | |
| 42 | —APTINYX INC | 1,883,244 | $693.0M | 0.05% | |
| 43 | —NABRIVA THERAPEUTICS PLC | 17,025 | $35.0M | 0.00% |